Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide.
We report the case of a newborn infant affected by congenital hyperinsulinism who developed cholelithiasis associated with cholestatic jaundice following treatment with octreotide, a somatostatin analogue.
G
G
Radetti
L
L
Gentili
C
C
Paganini
H
H
Messner
D002769:Cholelithiasis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy*; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D015282:Octreotide / Q000008:administration & dosage / Q000009:adverse effects*; D014463:Ultrasonography
D015282:Octreotide